Drug Trial Radar · NCT06366698
Intravenous Iron Versus Oral Iron for the Treatment of Iron Deficiency Anemia
Last checked: Nov 20, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
518
Actual
Start
Nov 21, 2023
Primary completion
Sep 12, 2025
Study completion Oct 30, 2026
Sponsor
- Lead sponsor
- Arrowhead Regional Medical CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 16, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study aims to assess whether administering intravenous iron early in pregnancy, compared to standard oral iron treatment, can enhance hemoglobin levels before delivery and reduce the need for blood transfusions in patients with iron deficiency anemia. Patients diagnosed with iron deficiency anemia were randomly assigned to receive either oral or intravenous iron. Before treatment initiation, patients completed a symptom questionnaire baseline hemoglobin, and ferritin levels were measured. Follow-up visits occurred four weeks later and at 24 to 28 weeks gestation, involving reassessment of symptoms, laboratory testing, and monitoring of treatment adherence. Final hemoglobin levels were determined before delivery, and data on the need for blood transfusion at delivery were recorded.
Conditions
- Iron Deficiency Anemia of Pregnancy
Interventions
Venofer 200 MG Per 10 ML InjectionDrug
200 mg IV every 2 days until the targeted dose
Ferrous sulfateDrug
Take 1 tablet every other day with lemon/orange juice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Hemoglobin differenceTime frame: Hemoglobin level obtained prior to treatment and then 4 weeks later
- Ferritin differenceTime frame: Ferritin level obtained prior to treatment and then 4 weeks later
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Arrowhead Regional Medical Center
Colton, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.